which operates the Express Scripts pharmacy benefit management company and the Accredo specialty pharmacy business as well as certain other medical care provider services. Across all of its businesses ...

Evernorth's Accredo arm will make a Humira biosimilar available to patients with no out-of-pocket costs, the company ...

Evernorth Health Services will offer Humira biosimilar products with no out-of-pocket cost through its Accredo specialty ...

Tricare beneficiaries may now receive specialty drugs at lower copays through Tricare Home Delivery, according to the ...

AbbVie (ABBV) shares were down 6% in the wake of its Q1 earnings report and news that Cigna (CI) plans to offer a Humira ...

Cigna plans to make close copies of AbbVie's blockbuster arthritis drug Humira available with no out-of-pocket payment to ...

In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services announced that it will have a Humira® biosimilar ...

Shares of AbbVie (NYSE:ABBV) sank on Friday after the pharmaceutical company reported first-quarter results. Despite beating ...

Texas town thrives by offering state and local corporate tax incentives, office retention incentives and tax abatements.

Anglo American has rejected BHP’s acquisition proposal of $38.88 billion, stating it significantly undervalues the company ...

Evernorth Health Services' initiative to offer Humira biosimilar with $0 out-of-pocket costs for patients. Save an average of ...

By Ben Glickman Cigna Group-owned Evernorth Health Services said Thursday it would provide a Humira biosimilar with no out-of-pocket fees starting in ...